Curis, Inc. , a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.
Curis stock last closed at $1.30, down 0.76% from the previous day, and has decreased 91.25% in one year. It has underperformed other stocks in the Biotechnology industry by 0.14 percentage points. Curis stock is currently +27.45% from its 52-week low of $1.02, and -92.35% from its 52-week high of $16.99.
As of Apr 21, 2025, there are 8.49M shares of CRIS outstanding. The market value of CRIS is $11.03M. In the last 24 hours, 42,348 CRIS shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy CRIS stock.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, you'll need to fill out some personal details so you are able to invest in CRIS today.
Now that you have created your account on the best free stock trading app, you can securely and quickly fund your account:
Check out the video below to see the process of depositing funds into your investment account.
After you have figured out the best place to buy Curis stock, it's very important to analyze their stock before you invest, so you actually wrap your head around the risk as well as the upside.
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on CRIS's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CRIS's true value.
You can access additional valuation research on CRIS's stock here.
Out of 1 sell side analysts who track CRIS, the consensus analyst rating on Curis is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Curis stock forecast page.
Last year, CRIS revenue was $10.91M. In the past 5 year, CRIS's revenue has gone up by 1.75% per year. This was slower than the Biotechnology industry average of 44.31%.
Dive into CRIS's earnings and revenue performance here.
Over the last 12 months, insiders at CRIS have not bought or sold any shares.
Research more about who owns CRIS shares here.
No, Curis doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two primary types of orders:
Press the Open Trade button and eToro will place the order.
If you require additional info about buying stocks on eToro, click the helpful video below:
Now that you own some CRIS shares, you'll want to keep up with your new investment.
Start a watchlist to keep track of your CRIS stock.
To summarize, here are the 6 steps to buy Curis stock:
If you are looking for a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get updates on your investment in Curis, click below.